Public and Independent Research Initiatives
Advancing scientific discovery through public funding and independent research, addressing global challenges and fostering breakthrough innovations
1
Precision Gene Editing for Huntington’s Disease Using MOF-Based CRISPR/Cas9 Nanocarriers
This project focuses on developing a library of MOF-based nanocarriers specifically designed for delivering CRISPR/Cas9 systems to neuronal cells to target and suppress mutant huntingtin (HTT) gene expression. By systematically mapping various MOF structures and their efficiency in crossing the blood-brain barrier and achieving precise gene editing, the aim is to create a comprehensive resource for advancing therapeutic strategies for Huntington’s disease.
2
Real-Time Monitoring of Dopamine and Novel Biomarkers for Early-Stage Parkinson’s Disease
This project focuses on designing a MOF-based electrochemical biosensor capable of detecting dopamine alongside emerging biomarkers such as alpha-synuclein aggregates. By integrating the analysis of these critical indicators, the biosensor aims to provide a comprehensive tool for the early diagnosis and monitoring of Parkinson’s disease progression.
3
Targeted CRISPR/Cas9 Delivery to Hepatic Stellate Cells in Liver Fibrosis
This project focuses on developing porous nanomaterials, including MOFs, as nanocarriers for the precise delivery of CRISPR/Cas9 to hepatic stellate cells, the primary mediators of liver fibrosis. By selectively targeting these cells, the aim is to explore gene-editing strategies that could reverse fibrosis progression and improve liver function in chronic liver disease.
4
MOF- and MXene-Encapsulated Dual-Drug Systems for Targeted Breast Cancer Therapy
This project investigates the use of MOF and MXene-based nanocarriers to deliver a combination of chemotherapy agents and targeted therapeutics specifically to triple-negative breast cancer cells. By encapsulating dual drugs within these porous materials, the goal is to enhance therapeutic efficacy while minimizing side effects through targeted delivery and controlled release.
5
Wearable Zr-Based MOF-Aptasensor for Early Detection of Neuroinflammation in Alzheimer's Disease
This project aims to develop a wearable biosensor utilizing Zr-based metal-organic frameworks (MOFs) combined with aptamers to detect early biomarkers of neuroinflammation in Alzheimer's disease. The sensor will enable real-time, non-invasive monitoring, offering a promising approach for early diagnosis and tracking disease progression in Alzheimer's patients.
6
Tailoring MOFs for Advanced Green Biomaterials: Exploring Physicochemical Properties to Revolutionize Biodegradable and Sustainable Technologies
This project focuses on the design and synthesis of innovative metal-organic frameworks (MOFs) with highly tunable porosity and surface functionalities to create next-generation green biomaterials. By investigating the intricate relationship between structural parameters such as pore architecture, metal-ligand interactions, and surface reactivity, the goal is to develop MOFs with enhanced biodegradability, sustainability, and catalytic properties, driving transformative applications in environmental remediation, sustainable packaging, and energy-efficient systems.

If you are interested in supporting cutting-edge research and contributing to innovative scientific advancements, I invite you to get in touch. Together, we can drive impactful solutions for global challenges in the fields of chemistry, nanomaterials, biotechnology, and sustainable technologies.